NON-SURGICAL AYURVEDIC MANAGEMENT OF CHOLELITHIASIS (PITTASHMARI): A CASE STUDY
Main Article Content
Keywords
Cholelithiasis, Cholecystectomy Pittashmari, Pittashaya
Abstract
Cholecystectomy, the surgical removal of the gallbladder, remains the standard and most widely practiced treatment for cholelithiasis (gallstones). Nevertheless, increasing attention has been directed toward non-surgical alternatives, as conventional surgery entails complete organ removal. Timely management of gallstones is crucial not only for symptomatic relief but also for preventing serious complications such as acute cholecystitis. However, current medical therapies provide limited efficacy and accessibility in the conservative management of cholelithiasis.
Existing non-surgical modalities—including extracorporeal shock wave lithotripsy (ESWL), contact dissolution therapy using methyl tertiary-butyl ether (MTBE), and oral bile acid therapy with ursodiol or chenodiol—have demonstrated varying degrees of success but are constrained by safety concerns, recurrence rates, and procedural limitations. Although percutaneous cholecystostomy offers a minimally invasive alternative, its indications remain restricted. While cholecystectomy achieves a recurrence prevention rate of approximately 99%, 10–15% of patients develop post-cholecystectomy syndrome, underscoring the unmet need for safe, effective, and organ-preserving therapeutic strategies.
This article endeavors to advance the discourse on developing novel, evidence-based, non-surgical modalities for the management of cholelithiasis—aiming to provide a safer and more holistic alternative to conventional surgical intervention.
References
2. Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH. Classification and nomenclature of gallstones revisited. Yonsei Med J. 2003;44(4):561–70.
3. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology. 1997;26:809–18.
4. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652–8.
5. Amaral JF, Thompson WR. Gallbladder disease in the morbidly obese. Am J Surg. 1985;149:551–7.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.
7. Ahlberg J, Angelin B, Einarsson K, Hellstrom K, Leijd B. Prevalence of gallbladder disease in hyperlipoproteinemia. Dig Dis Sci. 1979;24:459–64.
8. Einarsson K, Hellstrom K, Kallner M. Gallbladder disease in hyperlipoproteinaemia. Lancet. 1975;1:484–7.
9. Einarsson K, Hellstrom K, Kallner M. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia. J Clin Invest. 1974;54:1301–11.
10. Nervi F, Miquel JF, Alvarez M, et al. Gallbladder disease is associated with insulin resistance in a high-risk Hispanic population. J Hepatol. 2006;45:299–305.
11. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease: a case-control study. Br Med J (Clin Res Ed). 1984;289:521–5.
12. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80:1–2.
13. Scragg RK, McMichael AJ, Seamark RF. Oral contraceptives, pregnancy, and endogenous oestrogen in gallstone disease–a case-control study. Br Med J (Clin Res Ed). 1984;288:1795–9.
14. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males: relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest. 1989;84:811–6.
15. Angelin B, Olivecrona H, Reihner E, et al. Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology. 1992;103:1657–63.
16. Lee DW, Gilmore CJ, Bonorris G, et al. Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects. Am J Clin Nutr. 1985;42:414–20.
17. Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gallstone disease: a case-control study. Br Med J (Clin Res Ed). 1984;288:1113–9.
18. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology. 2005;129:105–12.
19. Nervi F, Covarrubias C, Bravo P, et al. Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men: identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area. Gastroenterology. 1989;96:825–30.
20. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med. 2004;141:514–22.
21. Leitzmann MF, Willett WC, Rimm EB, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA. 1999;281:2106–12.
22. Leitzmann MF, Giovannucci EL, Stampfer MJ, et al. Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. Alcohol Clin Exp Res. 1999;23:835–41.
23. Leitzmann MF, Giovannucci EL, Rimm EB, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med. 1998;128:417–25.
24. Leitzmann MF, Rimm EB, Willett WC, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med. 1999;341:777–84.
25. Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med. 1989;149:1750–3.
26. Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005;41:1322–8.
27. Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med. 1999;130:471–7.
28. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern Med. 2006;166:2369–74.
29. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995;98:115–7.
30. Angelin B, Einarsson K, Leijd B. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid. Eur J Clin Invest. 1981;11:185–9.
31. Angelin B, Einarsson K, Leijd B. Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest. 1979;9:185–90.
32. Grundy SM, Vega GL. Fibric acids: effects on lipids and lipoprotein metabolism. Am J Med. 1987;83:9–20.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Durgesh Kumar
Assistant Professor, Department of Shalya Tantra, Institute of Ayurveda ,Major SD Singh university Farukhbad Uttar Pradesh 209749, Email:- Durgeshsaini776@gmail.com
Dr.Chandrabhan Singh Gurjar
Assistant Professor,Department of Shalya Tantra,Depertment of Ayurveda and community IES University Ratibad road Bhopal, Email:- chandrabhan.gurjar1991@gmail.com
Dr. Suneel Kumar Rajpoot
Assistant Professor, Department of Shalya Tantra, Institute of Ayurveda ,Major SD Singh university Farukhbad Uttar Pradesh 209749, Email:-Mahan.suneel72@gmail.com
Dr. Ratan Singh
Associate Professor ,Department of Swasthavritta Evam Yoga ,Institute of Ayurveda Major SD Singh University, Farrukhabad ,U.P., 209749, Email ID-singh.ratan21685@gmail.com, Orchid ID- 0000-0002-6938-575X
